Oncopeptides Ab Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ONCOPEPTIDES AB, and what generic alternatives to ONCOPEPTIDES AB drugs are available?
ONCOPEPTIDES AB has one approved drug.
There are six US patents protecting ONCOPEPTIDES AB drugs.
There are eighty-seven patent family members on ONCOPEPTIDES AB drugs in thirty-one countries and nine supplementary protection certificates in eight countries.
Summary for Oncopeptides Ab
| International Patents: | 87 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Oncopeptides Ab
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncopeptides Ab | PEPAXTO | melphalan flufenamide hydrochloride | POWDER;INTRAVENOUS | 214383-001 | Feb 26, 2021 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Oncopeptides Ab | PEPAXTO | melphalan flufenamide hydrochloride | POWDER;INTRAVENOUS | 214383-001 | Feb 26, 2021 | DISCN | Yes | No | 6,992,207 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Oncopeptides Ab | PEPAXTO | melphalan flufenamide hydrochloride | POWDER;INTRAVENOUS | 214383-001 | Feb 26, 2021 | DISCN | Yes | No | 10,869,928 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Oncopeptides Ab Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Slovenia | 2701720 | ⤷ Try a Trial |
| Mexico | 365205 | ⤷ Try a Trial |
| Germany | 60141398 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Oncopeptides Ab Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2701720 | C202330006 | Spain | ⤷ Try a Trial | PRODUCT NAME: CLORHIDRATO DE MELFALAN FLUFENAMIDA; NATIONAL AUTHORISATION NUMBER: EU/1/22/1669; DATE OF AUTHORISATION: 20220817; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/22/1669; DATE OF FIRST AUTHORISATION IN EEA: 20220817 |
| 2701720 | 23C1000 | France | ⤷ Try a Trial | PRODUCT NAME: MELPHALAN FLUFENAMIDE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, TELS QUE LE CHLORHYDRATE; REGISTRATION NO/DATE: EU/1/22/1669 20220818 |
| 2701720 | 301206 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: MELPHALAN FLUFENAMIDE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/22/1669 20220818 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
